ADIENNE is able to take on various productions from early stages up to the commercialization of biological products
In addition to the manufactoring of own products and thanks to its twenty-year experience, ADIENNE is working as a CDMO for new projects, defining the best development and implementation strategy for new processes in order to optimize the time to market of the molecule of interest.
Our expertise covers the production of recombinant proteins, vaccines and Antibody Drug Conjugates (ADCs)
Our plant and equipment allow us to start from bench scale processes and define a scale up to achieve commercial production volumes in full compliance with GMP.
In fact, our facility is designed to handle volumes ranging from a few milliliters up to batch sizes of one thousand liters, both in the upstream and downstream phase.
Our processes
which start from the cell banks stored in our plant and go through the upstream & downstream production steps, continue with a fully automated aseptic filling and are completed with the inspection and packaging phases.
Finally, our Quality Control laboratory enables us to internally manage all analytical activities related to biotechnological productions (both chemical and microbiological analyses).
ADIENNE has all the expertise and facilities to manage the life-cycle of biological productions in-house
taking care of all analytical and validation activities that accompany this type of processing.
Our regulatory team is also able to identify the best strategy that allows us to proceed with the registration of the product.
